A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes
Journal of Clinical Medicine · 13.04.2023 · 12 (8) · 2846
DOI: 10.3390/jcm12082846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.04.2023. Verfasst von Claire McGee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Torrens University Australia, Sydney, NSW 2000, Australia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Symbyx Pty Ltd..
Abstract (Originalsprache)
Emerging evidence is increasingly supporting the use of transcranial photobiomodulation (tPBM) to improve symptoms of neurodegenerative diseases, including Parkinson’s disease (PD). The objective of this study was to analyse the safety and efficacy of tPBM for PD motor symptoms. The study was a triple blind, randomized placebo-controlled trial with 40 idiopathic PD patients receiving either active tPBM (635 nm plus 810 nm LEDs) or sham tPBM for 24 min per day (56.88J), six days per week, for 12 weeks. The primary outcome measures were treatment safety and a 37-item MDS-UPDRS-III (motor domain) assessed at baseline and 12 weeks. Individual MDS-UPDRS-III items were clustered into sub-score domains (facial, upper-limb, lower-limb, gait, and tremor). The treatment produced no safety concerns or adverse events, apart from occasional temporary and minor dizziness. There was no significant difference in total MDS-UPDRS-III scores between groups, presumably due to the placebo effect. Additional analyses demonstrated that facial and lower-limb sub-scores significantly improved with active treatment, while gait and lower-limb sub-scores significantly improved with sham treatment. Approximately 70% of participants responded to active treatment (≥5 decrease in MDS-UPDRS-III score) and improved in all sub-scores, while sham responders improved in lower-limb sub-scores only. tPBM appears to be a safe treatment and improved several PD motor symptoms in patients that responded to treatment. tPBM is proving to be increasingly attractive as a possible non-pharmaceutical adjunct therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences, Torrens University Australia, Sydney, NSW 2000, Australia.
- School of Medical Sciences, University of Sydney, Camperdown, NSW 2050, Australia.
- Department of Research and Governance, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia.
- NICM Health Research Institute, University of Western Sydney, Westmead, NSW 2145, Australia.
- School of Allied Health, Exercise & Sports Sciences, Faculty of Science & Health, Charles Sturt University, Albury Campus, Albury, NSW 2640, Australia.
- Centre for Healthy Futures, Torrens University Australia, Sydney, NSW 2000, Australia.
ORCID-Profile: Vivian Isaac, Craig S McLachlan, Hosen Kiat, Geoffrey Herkes
Förderung
- Symbyx Pty Ltd.
Zitieren
APA
McGee, C., Liebert, A., Bicknell, B., Pang, V., Isaac, V., McLachlan, C. S., Kiat, H., & Herkes, G. (2023). A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes. Journal of Clinical Medicine, 12(8), 2846. https://doi.org/10.3390/jcm12082846
Vancouver
McGee C, Liebert A, Bicknell B, Pang V, Isaac V, McLachlan CS, et al. A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes. Journal of Clinical Medicine. 2023;12(8):2846. doi:10.3390/jcm12082846
BibTeX
@article{McGee2023,
author = {McGee, Claire and Liebert, Ann and Bicknell, Brian and Pang, Vincent and Isaac, Vivian and McLachlan, Craig S and Kiat, Hosen and Herkes, Geoffrey},
title = {A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {8},
pages = {2846},
doi = {10.3390/jcm12082846}
}
EUVIMED